Racial disparities in patients with TP53 mutated acute myeloid leukemia.

被引：0

作者：

Badar, Talha

Litzow, Mark Robert

Shallis, Rory

Stahl, Maximilian

Bewersdorf, Jan Philipp

Saliba, Antoine N.

Correia, Guilherme Sacchi De Camargo

Patel, Anand Ashwin

Abaza, Yasmin

Murthy, Guru Subramanian Guru

Duvall, Adam

Burkart, Madelyn

Al-Kali, Aref

Palmisiano, Neil

Dinner, Shira

Goldberg, Aaron David

Atallah, Ehab L.

机构：

[1] Mayo Clin, Jacksonville, FL USA

[2] Mayo Clin, Div Hematol, Rochester, MN USA

[3] Yale Sch Med, New Haven, CT USA

[4] Mem Sloan Kettering Canc Ctr, New York, NY USA

[5] Yale Univ Sch Med, New Haven, CT USA

[6] Mt Sanai Hosp, New York, NY USA

[7] Univ Chicago, Chicago, IL USA

[8] Northwestern Mem Hosp, Chicago, IL USA

[9] Med Coll Wisconsin, Div Hematol Oncol, Milwaukee, WI USA

[10] Univ Chicago Med, Chicago, IL USA

[11] Thomas Jefferson Univ Hosp, Philadelphia, PA USA

[12] Med Coll Wisconsin, Milwaukee, WI USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e19007

引用

页码：E19007 / E19007

页数：1

共 50 条

[21] Clinical and prognostic values of TP53 mutation in patients with acute myeloid leukemia
张莹
ChinaMedicalAbstracts(InternalMedicine), 2020, 37 (01) : 59 - 59
[22] TP53 mutations in older adults with acute myeloid leukemia
Masamitsu Yanada
Yukiya Yamamoto
Sachiko Iba
Akinao Okamoto
Yoko Inaguma
Masutaka Tokuda
Satoko Morishima
Tadaharu Kanie
Shuichi Mizuta
Yoshiki Akatsuka
Masataka Okamoto
Nobuhiko Emi
International Journal of Hematology, 2016, 103 : 429 - 435
[23] Functional Classification of TP53 Mutations in Acute Myeloid Leukemia
Dutta, Sayantanee
Pregartner, Gudrun
Ruecker, Frank G.
Heitzer, Ellen
Zebisch, Armin
Bullinger, Lars
Berghold, Andrea
Doehner, Konstanze
Sill, Heinz
BLOOD, 2019, 134
[24] Functional Classification of TP53 Mutations in Acute Myeloid Leukemia
Dutta, Sayantanee
Pregartner, Gudrun
Ruecker, Frank G.
Heitzer, Ellen
Zebisch, Armin
Bullinger, Lars
Berghold, Andrea
Doehner, Konstanze
Sill, Heinz
CANCERS, 2020, 12 (03)
[25] Acute myeloid leukemia with mutated TP53: Is this newly proposed entity oversimplifying a complex group of neoplasms?
Fang, Hong
Medeiros, L. Jeffery
Wang, Wei
AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (12) : E354 - E355
[26] Are We Moving the Needle for Patients with TP53-Mutated Acute Myeloid Leukemia?
Shallis, Rory M.
Bewersdorf, Jan P.
Stahl, Maximilian F.
Halene, Stephanie
Zeidan, Amer M.
CANCERS, 2022, 14 (10)
[27] Precision medicine for TP53-mutated acute myeloid leukemia
Brattas, Marte Karen
Reikvam, Hakon
Tvedt, Tor Henrik Anderson
Bruserud, Oystein
EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2019, 4 (05): : 263 - 274
[28] Is TP53 Mutated AML the Same Disease as TP53 Mutated MDS?
Valk, Peter J. M.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S3 - S5
[29] SELECTION OF A PRE-EXISTING TP53 MUTATED CLONE IN THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Schulz, E.
Kashofer, K.
Mhatre, K. N.
Hoefler, G.
Sill, H.
HAEMATOLOGICA, 2014, 99 : 15 - 15
[30] Therapeutic Vulnerabilities in Acute Myeloid Leukemia (AML) with <it>TP53</it> Alterations
Ogunsan, Oluwateniayo
Antony, Marie
Noble-Orcutt, Klara
He, Fiona
Sachs, Zohar
FASEB JOURNAL, 2020, 34

← 1 2 3 4 5 →